Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Non-Current Assets (2016 - 2025)

Angiodynamics (ANGO) has disclosed Non-Current Assets for 15 consecutive years, with $108.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets changed N/A year-over-year to $108.3 million, compared with a TTM value of $442.3 million through Nov 2025, changed N/A, and an annual FY2025 reading of $111.8 million, changed N/A over the prior year.
  • Non-Current Assets was $108.3 million for Q4 2025 at Angiodynamics, down from $109.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $436.6 million in Q1 2021 and bottomed at -$196.9 million in Q1 2024.
  • Average Non-Current Assets over 5 years is $266.6 million, with a median of $379.7 million recorded in 2023.
  • The sharpest move saw Non-Current Assets crashed 154.2% in 2024, then skyrocketed 163.15% in 2025.
  • Year by year, Non-Current Assets stood at $421.9 million in 2021, then decreased by 5.34% to $399.4 million in 2022, then decreased by 21.34% to $314.1 million in 2023, then tumbled by 154.94% to -$172.6 million in 2024, then soared by 162.77% to $108.3 million in 2025.
  • Business Quant data shows Non-Current Assets for ANGO at $108.3 million in Q4 2025, $109.0 million in Q3 2025, and $111.8 million in Q2 2025.